Alan Ashbaugh

689 total citations
27 papers, 385 citations indexed

About

Alan Ashbaugh is a scholar working on Epidemiology, Infectious Diseases and Organic Chemistry. According to data from OpenAlex, Alan Ashbaugh has authored 27 papers receiving a total of 385 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Epidemiology, 14 papers in Infectious Diseases and 12 papers in Organic Chemistry. Recurrent topics in Alan Ashbaugh's work include Pneumocystis jirovecii pneumonia detection and treatment (26 papers), Antifungal resistance and susceptibility (11 papers) and Synthesis and Biological Evaluation (11 papers). Alan Ashbaugh is often cited by papers focused on Pneumocystis jirovecii pneumonia detection and treatment (26 papers), Antifungal resistance and susceptibility (11 papers) and Synthesis and Biological Evaluation (11 papers). Alan Ashbaugh collaborates with scholars based in United States and Switzerland. Alan Ashbaugh's co-authors include Melanie T. Cushion, Michael J. Linke, Peter D. Walzer, Margaret S. Collins, Reiko Tanaka, Judith Koch, Voon Ong, Santiago Rodríguez López, Lynn Miesel and Iwao Ojima and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Alan Ashbaugh

25 papers receiving 382 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alan Ashbaugh United States 10 320 264 67 40 21 27 385
Rosie Jaramillo United States 10 284 0.9× 318 1.2× 34 0.5× 25 0.6× 33 1.6× 12 348
Dustin Wilson United States 7 176 0.6× 247 0.9× 84 1.3× 49 1.2× 23 1.1× 14 371
N C Karyotakis United States 8 166 0.5× 246 0.9× 35 0.5× 32 0.8× 9 0.4× 10 288
Carmen A. Molina-Torres Mexico 11 202 0.6× 208 0.8× 35 0.5× 74 1.9× 9 0.4× 25 321
Maria Cristina da Silva Lourenço Brazil 9 133 0.4× 144 0.5× 86 1.3× 59 1.5× 9 0.4× 26 306
Kazutaka Nakamoto Japan 7 282 0.9× 349 1.3× 75 1.1× 99 2.5× 74 3.5× 9 465
Christiane Chastin France 10 223 0.7× 273 1.0× 18 0.3× 84 2.1× 64 3.0× 12 328
C. Bellucci Italy 3 211 0.7× 251 1.0× 43 0.6× 77 1.9× 46 2.2× 4 367
W. HOEKSTRA United States 6 227 0.7× 246 0.9× 60 0.9× 44 1.1× 18 0.9× 7 330
Graham E. M. Sibley United Kingdom 7 202 0.6× 261 1.0× 74 1.1× 74 1.9× 36 1.7× 8 447

Countries citing papers authored by Alan Ashbaugh

Since Specialization
Citations

This map shows the geographic impact of Alan Ashbaugh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan Ashbaugh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan Ashbaugh more than expected).

Fields of papers citing papers by Alan Ashbaugh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan Ashbaugh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan Ashbaugh. The network helps show where Alan Ashbaugh may publish in the future.

Co-authorship network of co-authors of Alan Ashbaugh

This figure shows the co-authorship network connecting the top 25 collaborators of Alan Ashbaugh. A scholar is included among the top collaborators of Alan Ashbaugh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan Ashbaugh. Alan Ashbaugh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ashbaugh, Alan, et al.. (2025). Single-cell RNA sequencing defines developmental progression and reproductive transitions of Pneumocystis carinii. Microbiology Spectrum. 13(10). e0127725–e0127725. 1 indexed citations
2.
Ashbaugh, Alan, et al.. (2024). Pneumocystis murina promotes inflammasome formation and NETosis during Pneumocystis pneumonia. mBio. 15(8). e0140924–e0140924. 4 indexed citations
3.
Porollo, Aleksey, et al.. (2024). Insights into copper sensing and tolerance in Pneumocystis species. Frontiers in Microbiology. 15. 1383737–1383737.
4.
Ashbaugh, Alan, et al.. (2022). The Effects of Sex and Strain on Pneumocystis murina Fungal Burdens in Mice. Journal of Fungi. 8(10). 1101–1101. 1 indexed citations
5.
Cushion, Melanie T., et al.. (2022). Anidulafungin Treatment Blocks the Sexual Cycle of Pneumocystis murina and Prevents Growth and Survival without Rescue by an Alternative Mode of Replication. Microbiology Spectrum. 10(6). e0290622–e0290622. 2 indexed citations
6.
Green, Jenna, Anne‐Karina T. Perl, Alan Ashbaugh, et al.. (2021). The Promise of Lung Organoids for Growth and Investigation of Pneumocystis Species. SHILAP Revista de lepidopterología. 2. 740845–740845. 5 indexed citations
7.
8.
Miesel, Lynn, Melanie T. Cushion, Alan Ashbaugh, Santiago Rodríguez López, & Voon Ong. (2020). Efficacy of Rezafungin in Prophylactic Mouse Models of Invasive Candidiasis, Aspergillosis, and Pneumocystis Pneumonia. Antimicrobial Agents and Chemotherapy. 65(3). 29 indexed citations
9.
Cushion, Melanie T. & Alan Ashbaugh. (2019). Rezafungin Prophylactic Efficacy in a Mouse Model of Pneumocystis Pneumonia. Biology of Blood and Marrow Transplantation. 25(3). S366–S366. 4 indexed citations
10.
11.
Liu, Guan‐Sheng, et al.. (2018). A quantitative systems pharmacology (QSP) model for Pneumocystis treatment in mice. BMC Systems Biology. 12(1). 77–77. 6 indexed citations
12.
Haranahalli, Krupanandan, Robert Rieger, Hari Krishna Ananthula, et al.. (2018). Acylhydrazones as Antifungal Agents Targeting the Synthesis of Fungal Sphingolipids. Antimicrobial Agents and Chemotherapy. 62(5). 54 indexed citations
13.
Linke, Michael J., et al.. (2013). Characterization of a Distinct Host Response Profile to Pneumocystismurina Asci during Clearance of Pneumocystis Pneumonia. Infection and Immunity. 81(3). 984–995. 23 indexed citations
14.
15.
Linke, Michael J., Alan Ashbaugh, Judith Koch, et al.. (2009). Effects of Surfactant Protein‐A on the Interaction of Pneumocystis murina with its Host at Different Stages of the Infection in Mice. Journal of Eukaryotic Microbiology. 56(1). 58–65. 5 indexed citations
16.
Linke, Michael J., Alan Ashbaugh, Judith Koch, Reiko Tanaka, & Peter D. Walzer. (2006). Efficient resolution of Pneumocystis murina infection in surfactant protein A-deficient mice following withdrawal of corticosteroid-induced immunosuppression. Journal of Medical Microbiology. 55(2). 143–147. 11 indexed citations
17.
Linke, Michael J., et al.. (2005). Resolution of Pneumocystis murina infection following withdrawal of corticosteroid induced immunosuppression. Microbial Pathogenesis. 40(1). 15–22. 9 indexed citations
18.
Linke, Michael J., Alan Ashbaugh, Judith Koch, Reiko Tanaka, & Peter D. Walzer. (2005). Surfactant protein A limits Pneumocystis murina infection in immunosuppressed C3H/HeN mice and modulates host response during infection. Microbes and Infection. 7(4). 748–759. 16 indexed citations
19.
Walzer, Peter D., Alan Ashbaugh, Margaret S. Collins, & Melanie T. Cushion. (2001). Anti–Human Immunodeficiency Virus Drugs Are Ineffective againstPneumocystis cariniiIn Vitro and In Vivo. The Journal of Infectious Diseases. 184(10). 1355–1357. 8 indexed citations
20.
Walzer, Peter D., Alan Ashbaugh, Margaret S. Collins, & Melanie T. Cushion. (2001). In Vitro and In Vivo Effects of Quinupristin-Dalfopristin against Pneumocystis carinii. Antimicrobial Agents and Chemotherapy. 45(11). 3234–3237. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rosie Jaramillo Breakdown of academic impact, for papers by Dustin Wilson Breakdown of academic impact, for papers by N C Karyotakis Breakdown of academic impact, for papers by Carmen A. Molina-Torres Breakdown of academic impact, for papers by Maria Cristina da Silva Lourenço Breakdown of academic impact, for papers by Kazutaka Nakamoto Breakdown of academic impact, for papers by Christiane Chastin Breakdown of academic impact, for papers by C. Bellucci Breakdown of academic impact, for papers by W. HOEKSTRA Breakdown of academic impact, for papers by Graham E. M. Sibley
Rankless by CCL
2026